Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/13/2024 | $8.50 | Overweight | Cantor Fitzgerald |
| 8/17/2022 | $8.00 | Underperform | Credit Suisse |
| 3/1/2022 | $22.00 → $23.00 | Underperform | BofA Securities |
| 3/1/2022 | $22.00 → $18.00 | Underweight | JP Morgan |
| 3/1/2022 | $33.00 → $18.00 | Hold | Craig Hallum |
| 3/1/2022 | $36.00 → $29.00 | Buy | Lake Street |
| 3/1/2022 | $24.00 → $22.00 | Neutral | B. Riley Securities |
| 11/8/2021 | $36.00 | Buy | Lake Street |
ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth in new hardware systems and related services was offset by a decline in materials sales driven primarily by inventory management in the dental aligner market.Previously announced $50 million cost savings initiative proceeding on schedule for completion by mid-2026. Reduction in operating expenses in Q1 continues to reflect the Company's focus on cost and efficiency.Company announcing an additional cost reduction initiative estimated to deliver $20 million incremental savings in 2025 to acceler
ROCK HILL, S.C., April 30, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the first quarter 2025 after the U.S. stock markets close on Monday, May 12, 2025. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, May 13, 2025 at 8:30 a.m. Eastern Time. First Quarter 2025 Financial Results Conference CallDate: Tuesday, May 13, 2025Time: 8:30 a.m. Eastern TimeListen via webcast: www.3dsystems.com/investorParticipate via telephone: 201-689-8345 The webcast replay will be available approximately two hours after the end of the conference call at www.3dsystems.com/investor.
ROCK HILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the fourth quarter and full year ended December 31, 2024. Full-year 2024 revenue of $440 million, above lower end of guidance range, inclusive of a $9 million revenue reduction in Q4 driven by a change in accounting estimates for Regenerative Medicine program milestone recognition. This change in estimate is related to the now anticipated use of pre-clinical human decedent testing, successfully demonstrated by our partner, United Therapeutics, which led to refinement of the milestone technical criteria.Continued reduction in operating expenses in Q4 reflectin
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
ROCK HILL, S.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) announced the appointment of Dr. Rebekah Gee to the 3D Systems Medical Advisory Board, effective March 1, 2023. Dr. Gee is a recognized expert on public health policy and was elected to the National Academy of Medicine in 2017. Dr. Gee will join six other members of the advisory board who have been named since the board's establishment in May 2022: Dr. Stephen K. Klasko, former President and CEO of Thomas Jefferson University and Jefferson Health;The Honorable David J. Shulkin, former U.S. Secretary of Veterans Affairs;The Honorable Alex Azar, former U.S. Health & Human Services Secretary;Dr. Toby Cosgrove, f
ROCK HILL, S.C., Jan. 05, 2023 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) today announced the appointment of Mr. Bert Bruce to the company's Medical Advisory Board. Mr. Bruce will join the five other members of the advisory board who have been named since the Board's establishment in May 2022: Dr. Stephen K. Klasko, former President and CEO of Thomas Jefferson University and Jefferson Health;The Honorable David J. Shulkin, former U.S. Secretary of Veterans Affairs;The Honorable Alex Azar, former U.S. Health & Human Services Secretary;Dr. Toby Cosgrove, former President & Chief Executive officer of the Cleveland Clinic; andDr. Bon Ku, Professor of Medicine and Design at Thomas Jefferson U
10-Q - 3D SYSTEMS CORP (0000910638) (Filer)
8-K - 3D SYSTEMS CORP (0000910638) (Filer)
DEFA14A - 3D SYSTEMS CORP (0000910638) (Filer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
SC 13G/A - 3D SYSTEMS CORP (0000910638) (Subject)
SC 13G - 3D SYSTEMS CORP (0000910638) (Subject)
SC 13G/A - 3D SYSTEMS CORP (0000910638) (Subject)
Cantor Fitzgerald initiated coverage of 3D Systems with a rating of Overweight and set a new price target of $8.50
Credit Suisse initiated coverage of 3D Systems with a rating of Underperform and set a new price target of $8.00
BofA Securities reiterated coverage of 3D Systems with a rating of Underperform and set a new price target of $23.00 from $22.00 previously
ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth in new hardware systems and related services was offset by a decline in materials sales driven primarily by inventory management in the dental aligner market.Previously announced $50 million cost savings initiative proceeding on schedule for completion by mid-2026. Reduction in operating expenses in Q1 continues to reflect the Company's focus on cost and efficiency.Company announcing an additional cost reduction initiative estimated to deliver $20 million incremental savings in 2025 to acceler
3D Systems' NextDent branded dental materials have set the benchmark for quality and aesthetics, addressing the broadest set of patient-specific dental solutions in the worldNextDent materials form the foundation for 3D Systems' dental ‘repair' offerings with regulatory approvals across the US, Europe and AsiaIndustry's largest portfolio of dental 3D printing materials seamlessly integrates with leading dental 3D printers across the industry, enabling improved production efficiency and aesthetics, reduced labor costs, and expanded service offerings3D Systems' solutions for the ‘repair' market are integral to its dental strategy, as the market is expected to be worth approximately $150 millio
ROCK HILL, S.C., April 30, 2025 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today it will release its financial results for the first quarter 2025 after the U.S. stock markets close on Monday, May 12, 2025. The company will hold a conference call and simultaneous webcast to discuss these financial results on Tuesday, May 13, 2025 at 8:30 a.m. Eastern Time. First Quarter 2025 Financial Results Conference CallDate: Tuesday, May 13, 2025Time: 8:30 a.m. Eastern TimeListen via webcast: www.3dsystems.com/investorParticipate via telephone: 201-689-8345 The webcast replay will be available approximately two hours after the end of the conference call at www.3dsystems.com/investor.
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)
4 - 3D SYSTEMS CORP (0000910638) (Issuer)